Madrigal Pharmaceuticals Inc (MDGL) — Financial Flexibility Index
Madrigal Pharmaceuticals Inc (MDGL) has a Financial Flexibility Index of -0.20x as of December 2025. Free cash flow of $-133.07 Million (operating CF $-133.46 Million minus capex $390.00K) represents 0% of total liabilities ($656.90 Million). Check Madrigal Pharmaceuticals Inc strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Madrigal Pharmaceuticals Inc Financial Flexibility Index (2003–2025)
Historical Financial Flexibility Index trend for Madrigal Pharmaceuticals Inc across 23 annual periods. See Madrigal Pharmaceuticals Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Madrigal Pharmaceuticals Inc (2003–2025)
Year-by-year free cash flow to debt coverage for Madrigal Pharmaceuticals Inc. For the full company profile including market capitalisation, see MDGL market cap.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.29x | $-189.09 Million | $-189.55 Million | $656.90 Million | ▲ +81.8% |
| 2024 | -1.58x | $-454.11 Million | $-455.57 Million | $287.86 Million | ▼ -15.0% |
| 2023 | -1.37x | $-322.75 Million | $-324.23 Million | $235.21 Million | ▼ -0.9% |
| 2022 | -1.36x | $-224.64 Million | $-224.86 Million | $165.18 Million | ▲ +42.8% |
| 2021 | -2.38x | $-183.71 Million | $-183.92 Million | $77.22 Million | ▲ +28.9% |
| 2020 | -3.34x | $-157.23 Million | $-157.56 Million | $47.02 Million | ▼ -105.6% |
| 2019 | -1.63x | $-41.45 Million | $-41.62 Million | $25.49 Million | ▲ +46.1% |
| 2018 | -3.02x | $-25.48 Million | $-25.51 Million | $8.44 Million | ▼ -36.7% |
| 2017 | -2.21x | $-22.19 Million | $-22.32 Million | $10.05 Million | ▲ +39.8% |
| 2016 | -3.67x | $-17.60 Million | $-17.61 Million | $4.80 Million | ▲ +8.6% |
| 2015 | -4.01x | $-71.39 Million | $-71.44 Million | $17.79 Million | ▼ -81.0% |
| 2014 | -2.22x | $-78.78 Million | $-78.92 Million | $35.54 Million | ▼ -33.4% |
| 2013 | -1.66x | $-76.64 Million | $-77.41 Million | $46.11 Million | ▲ +13.4% |
| 2012 | -1.92x | $-53.63 Million | $-54.13 Million | $27.95 Million | ▼ -13.4% |
| 2011 | -1.69x | $-46.61 Million | $-47.30 Million | $27.55 Million | ▼ -36.0% |
| 2010 | -1.24x | $-38.06 Million | $-38.20 Million | $30.59 Million | ▼ -13.3% |
| 2009 | -1.10x | $-26.36 Million | $-26.81 Million | $24.00 Million | ▼ -379.3% |
| 2008 | -0.23x | $-35.76 Million | $-37.94 Million | $156.04 Million | ▼ -175.7% |
| 2007 | 0.30x | $29.57 Million | $27.22 Million | $97.75 Million | ▲ +133.3% |
| 2006 | -0.91x | $-51.41 Million | $-52.98 Million | $56.54 Million | ▲ +70.1% |
| 2005 | -3.04x | $-57.00 Million | $-61.88 Million | $18.73 Million | ▼ -32.9% |
| 2004 | -2.29x | $-32.20 Million | $-33.80 Million | $14.06 Million | ▲ +65.0% |
| 2003 | -6.53x | $-22.84 Million | $-23.61 Million | $3.50 Million | — |